Ati cautat: interactiuni medicamente
Protocol terapeutic: N07XX11 – DCI PITOLISANTUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: N03AX23 – DCI BRIVARACETAMUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: L01XC16 – DCI DINUTUXIMAB BETA (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: J05AP56 – DCI SOFOSBUVIRUM+VELPATASVIRUM+VOXILAPREVIRUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: A16AX03 – DCI NATRII PHENYLBUTYRATE (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: A16AB17 – DCI CERLIPONASUM ALFA (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: N028F – DCI PALIPERIDONUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: L01XE39 – DCI MIDOSTAURINUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: A10BJ02 DCI LIRAGLUTIDUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: A10AE06 – DCI INSULINUM DEGLUDEC (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
